Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Managing PCOS is hard because it varies a lot, treatments are limited, and there's a lot of false information online.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The Nd:YAG laser safely reduces facial hair and slows regrowth, with patient satisfaction.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.